A systems perspective begins to emerge in Alzheimer's.
Castellino
A
A
D015094:3-Hydroxyacyl CoA Dehydrogenases; D000544:Alzheimer Disease / Q000209:etiology* / Q000235:genetics* / Q000473:pathology; D016229:Amyloid beta-Peptides / Q000235:genetics*; D000818:Animals; D001057:Apolipoproteins E / Q000235:genetics / Q000378:metabolism; D017209:Apoptosis; D001921:Brain / Q000378:metabolism; D002091:Butyrylcholinesterase / Q000235:genetics; D002352:Carrier Proteins / Q000235:genetics* / Q000378:metabolism; D002868:Chromosomal Proteins, Non-Histone; D002869:Chromosome Aberrations; D018076:DNA, Complementary / Q000032:analysis; D004797:Enzyme-Linked Immunosorbent Assay; D015971:Gene Expression Regulation, Enzymologic / Q000235:genetics; D020022:Genetic Predisposition to Disease; D006367:HeLa Cells; D006801:Humans; D051379:Mice; D012307:Risk Factors
D016229:Amyloid beta-Peptides; D001057:Apolipoproteins E; D002352:Carrier Proteins; D002868:Chromosomal Proteins, Non-Histone; D018076:DNA, Complementary; D015094:3-Hydroxyacyl CoA Dehydrogenases; C108634:HSD17B10 protein, human; C458480:Hsd17b10 protein, mouse; D002091:Butyrylcholinesterase